Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
184B5
NM
Basal
Sirolimus
MTOR
MTOR
7789.068
uM
inf
inf
-0.9304 -0.9304 0.0000 1.0723
0.4470
0.3219
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7793.018
uM
inf
inf
0.9318 0.9318 0.0000 0.0067
0.3477
1.3186
HCC1187
TNBC
Basal A
Dactolisib
PI3K
PI3K
10753.146
uM
inf
inf
0.7845 0.7845 0.0000 0.1084
0.4052
1.4503
HCC1187
TNBC
Basal A
Dichloroacetate
PDK
PDK
13726.176
uM
inf
inf
0.6786 0.6786 0.0000 0.3517
-0.3654
0.4071
HCC1187
TNBC
Basal A
Dichloroacetate
PDK
PDK
12696.176
uM
inf
inf
0.6436 0.6436 0.0000 0.1782
0.0793
0.5469
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
9035.018
uM
inf
inf
0.9083 0.9083 0.0000 0.0297
0.4162
2.1555
LY2
HR+
Luminal
Cetuximab
EGFR
ErbB
7865.018
uM
inf
inf
-0.1870 -0.1870 0.0000 0.5240
-0.0010
1.1920
SUM159PT
TNBC
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7531.095
uM
inf
inf
0.9518 0.9518 0.0000 0.0484
0.3294
3.5302
SUM159PT
TNBC
Basal B
PS-1145
IKK
NFKB
7531.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0370
-7.5867
3.4461
MB 157
Unknown
Unknown
Sirolimus
MTOR
MTOR
9039.068
uM
inf
inf
0.0730 0.0730 0.0000 0.5500
0.5032
0.4510
HCC1954
HER2amp
Basal A
TPCA-1
IKK
NFKB
7454.093
uM
inf
inf
0.7670 0.7670 0.0000 0.2123
-0.1144
1.3347
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7794.018
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
1.6812
SUM159PT
TNBC
Basal B
Ro 32-0432
PKC
PKC
10520.142
uM
inf
inf
1.0500 1.0500 0.0000 -0.0236
-0.3274
3.1766
600MPE
HR+
Luminal
PS-1145
IKK
NFKB
5899.065
uM
inf
inf
0.8491 0.8491 0.0000 0.1182
0.0000
1.0946
HCC38
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
7469.098
uM
inf
inf
0.9936 0.9936 0.0000 0.0222
0.1591
2.0111
LY2
HR+
Luminal
SB-3CT
MMP2/9
MMP
10816.144
uM
inf
inf
0.9453 0.9453 0.0000 -0.0111
-0.0185
0.9146
184A1
NM
Basal
GSK923295
CENPE
Kinesin
9047.001
uM
inf
inf
0.0385 0.0385 0.0000 0.2510
0.5226
0.7701
HBL-100
Unknown
Unknown
Cetuximab
EGFR
ErbB
7808.052
uM
inf
inf
0.9944 0.9944 0.0000 -0.0231
-0.8225
2.4842
MDA-MB-134-VI
HR+
Luminal
PD184352
MEK
MAPK
10998.155
uM
inf
inf
0.6159 0.6159 0.0000 0.1450
0.0719
0.9302
LY2
HR+
Luminal
MG-132
Proteasome
Proteasome
14134.189
uM
inf
inf
-0.3706 -0.3706 0.0000 0.2938
0.5072
2.7572
SUM159PT
TNBC
Basal B
Sulindac sulfide
COX1/2
COX
10520.136
uM
inf
inf
0.9767 0.9767 0.0000 -0.0015
0.0597
4.0331
MDA-MB-415
HR+
Luminal
JNK-IN-5A
JNK
JNK
10938.144
uM
inf
inf
0.4357 0.4357 0.0000 0.4162
0.0687
1.1369
SUM159PT
TNBC
Basal B
TAPI-0
TACE/Collagenase
7531.096
uM
inf
inf
0.8694 0.8694 0.0000 0.0391
0.3982
3.5504
HCC38
TNBC
Basal B
Ribavirin
15351.211
uM
inf
inf
0.7443 0.7443 0.0000 0.0613
-0.0247
1.0866
HCC70
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7470.095
uM
inf
inf
0.6946 0.6946 0.0000 0.1485
0.1176
1.1893